← Back to Search

GLP-1 Receptor Agonist

Medically tailored meals for Obesity

N/A

Recruiting

Led By Kelseanna Hollis-Hansen, PhD, MPH

Research Sponsored by University of Texas Southwestern Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 4-months

Awards & highlights

Study Summary

"This trial discusses how patients tend to regain weight after stopping GLP-1 medications, which are expensive and may not be covered by insurance in the long term. Patients may also struggle with taking these medications

Who is the study for?

This trial is for adults who've lost over 10% of their body weight using GLP-1 receptor agonist medications, have stopped taking these meds within the last month, can consent to participate, and are fluent in English. It's not specified who cannot join.Check my eligibility

What is being tested?

The study explores if usual care, medically tailored meals or a digital health program called Noom® can help maintain weight loss after stopping obesity medication (GLP-1s). The goal is to find cost-effective ways to keep the weight off long-term.See study design

What are the potential side effects?

Since this trial tests non-medical interventions like special meals and a health app, side effects may be minimal compared to drug treatments. However, changes in diet or lifestyle adjustments could cause digestive changes or psychological impacts.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 4-months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~4-months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 4-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Intervention Adherence

Intervention Satisfaction

Secondary outcome measures

Diet quality

Percent weight loss maintained

Other outcome measures

Incremental cost effective ratio (ICER)

Trial Design

3Treatment groups

Experimental Treatment

Placebo Group

Group I: Noom®Experimental Treatment2 Interventions

Participants will receive a paid Noom® subscription for four-months. Noom® is a subscription-based mobile application that provides food intake and exercise tracking and uses principles from psychology to motivate behavior change.

Group II: Medically tailored mealsExperimental Treatment2 Interventions

Participants will receive 10 medically tailored meals per week (40 meals per month) for four-months.

Group III: Usual carePlacebo Group1 Intervention

Participants will receive usual care from their provider.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

UT Southwestern Nutrition Obesity Research CenterUNKNOWN

University of Texas Southwestern Medical CenterLead Sponsor

1,048 Previous Clinical Trials

1,053,675 Total Patients Enrolled

23 Trials studying Obesity

5,399 Patients Enrolled for Obesity

Kelseanna Hollis-Hansen, PhD, MPHPrincipal InvestigatorUT Southwestern Medical Center

2 Previous Clinical Trials

245 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new patients currently being enrolled in this ongoing medical study?

"Indeed, the details on clinicaltrials.gov imply that this particular research study is actively seeking volunteers. Originally shared on March 5th, 2024, with the most recent update provided on March 7th, 2024. The investigation aims to enroll a total of 60 participants from one designated site."

Answered by AI

What is the current number of participants undergoing examination in this particular investigation?

"Yes, as per the details on clinicaltrials.gov, this medical research study is actively seeking volunteers. It was initially listed on March 5th, 2024 and last modified on March 7th, 2024. The trial aims to enroll a total of 60 participants at one specific site."

Answered by AI